PLoS ONE
(Jan 2024)
Economic evaluation of trastuzumab in HER2-positive early breast cancer in Indonesia: A cost-effectiveness analysis
- Sudewi Mukaromah Khoirunnisa,
- Fithria Dyah Ayu Suryanegara,
- Didik Setiawan,
- Maarten Jacobus Postma,
- Lisa Aniek de Jong
Affiliations
- Sudewi Mukaromah Khoirunnisa
- Fithria Dyah Ayu Suryanegara
- Didik Setiawan
- Maarten Jacobus Postma
- Lisa Aniek de Jong
- Journal volume & issue
-
Vol. 19,
no. 5
WeChat QR code